AU2001275400A1 - Low molecular weight polymeric compositions - Google Patents

Low molecular weight polymeric compositions

Info

Publication number
AU2001275400A1
AU2001275400A1 AU2001275400A AU7540001A AU2001275400A1 AU 2001275400 A1 AU2001275400 A1 AU 2001275400A1 AU 2001275400 A AU2001275400 A AU 2001275400A AU 7540001 A AU7540001 A AU 7540001A AU 2001275400 A1 AU2001275400 A1 AU 2001275400A1
Authority
AU
Australia
Prior art keywords
molecular weight
low molecular
polymeric compositions
weight polymeric
devices
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001275400A
Inventor
James W. Burns
Robert J. Miller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genzyme Corp
Original Assignee
Genzyme Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genzyme Corp filed Critical Genzyme Corp
Publication of AU2001275400A1 publication Critical patent/AU2001275400A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L17/00—Materials for surgical sutures or for ligaturing blood vessels ; Materials for prostheses or catheters
    • A61L17/06—At least partially resorbable materials
    • A61L17/10—At least partially resorbable materials containing macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/041—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/042—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Surgery (AREA)
  • Vascular Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Materials Engineering (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Carboxymethylcellulose compositions having a molecular weight of less than about 100 kdaltons are provided for preparing medical implants, devices and implantable pharmaceutical preparations. The medical implants, devices and implantable pharmaceutical preparations and drug delivery devices of this invention are advantageously bioabsorbed by the subject within 30 days of the date of implantation.
AU2001275400A 2000-06-09 2001-06-07 Low molecular weight polymeric compositions Abandoned AU2001275400A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US59137300A 2000-06-09 2000-06-09
US09591373 2000-06-09
PCT/US2001/018592 WO2001095875A1 (en) 2000-06-09 2001-06-07 Low molecular weight polymeric compositions

Publications (1)

Publication Number Publication Date
AU2001275400A1 true AU2001275400A1 (en) 2001-12-24

Family

ID=24366237

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001275400A Abandoned AU2001275400A1 (en) 2000-06-09 2001-06-07 Low molecular weight polymeric compositions

Country Status (8)

Country Link
EP (1) EP1299083B1 (en)
JP (1) JP2004503483A (en)
AT (1) ATE293955T1 (en)
AU (1) AU2001275400A1 (en)
CA (1) CA2409431A1 (en)
DE (1) DE60110421T2 (en)
IL (1) IL153000A0 (en)
WO (1) WO2001095875A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITTO20040918A1 (en) * 2004-12-29 2005-03-29 Luigi Ambrosio POLYMERIC HYDROGEL BIODEGRADABLE ABSORBERS AND PROCEDURE FOR THEIR PREPARATION
WO2009148985A2 (en) * 2008-06-03 2009-12-10 E. I. Du Pont De Nemours And Company A tissue coating for preventing undesired tissue-to-tissue adhesions
US9254332B2 (en) 2013-03-15 2016-02-09 Arecor Limited Stable aqueous formulations of adenovirus vectors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6174999B1 (en) * 1987-09-18 2001-01-16 Genzyme Corporation Water insoluble derivatives of polyanionic polysaccharides
IN192791B (en) * 1996-06-28 2004-05-22 Johnson & Johnson Medical

Also Published As

Publication number Publication date
IL153000A0 (en) 2003-06-24
DE60110421T2 (en) 2006-02-02
ATE293955T1 (en) 2005-05-15
EP1299083A1 (en) 2003-04-09
JP2004503483A (en) 2004-02-05
WO2001095875A1 (en) 2001-12-20
CA2409431A1 (en) 2001-12-20
EP1299083B1 (en) 2005-04-27
DE60110421D1 (en) 2005-06-02

Similar Documents

Publication Publication Date Title
AU1525001A (en) A bioabsorbable drug delivery system
AU2003245282A1 (en) Stent coatings with sustained drug release rate
WO2007015739A3 (en) Pea-tempo/pea-bz coatings for controlled delivery of drugs from implantable medical devices
MXPA03007837A (en) Compositions for delivering bisphosphonates.
ES2184895T3 (en) NON-POLYMERIC ADMINISTRATION SYSTEM WITH DELAYED LIBERATION.
DK1392254T3 (en) Micelle drug delivery system for hydrophobic drugs
NZ501066A (en) Pharmaceutical formulations containing voriconazole and sulphobutylether beta-cyclodextrin
AU2001231196A1 (en) Delivery of therapeutic biological from implantable tissue matrices
WO2005027794A3 (en) Medical devices
AU1999995A (en) An adjunctive polymer system for use with medical device
BR0212475A (en) Pharmaceutical Compositions
WO2005011769A3 (en) Implantable or insertable medical devices containing acrylic copolymer for controlled delivery of therapeutic agent
WO2002067895A3 (en) Implant dosage form and use thereof for the delivery of a cholesterol lowering agent
WO2001043749A3 (en) Pharmaceutical implant containing immediate-release and sustained-release components and method of administration
CA2314863A1 (en) Radial head implant system including modular implants, sizers and instrumentation
AU2573499A (en) Implantable drug infusion device having an improved valve
MXPA02011891A (en) Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds.
AU2002239342A1 (en) Treatment of mucositis
WO2000041681A3 (en) MEDICINAL FORMULATIONS CONTAINING AN OPIOID AND AN α-ANTAGONIST
SG52240A1 (en) The use of cetrorelix and other nona-and decapeptides in the preparation of a medicament for combating aids and for growth stimulation
AU2001296865A1 (en) (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents
AU2546401A (en) Dental prosthesis with means for the release of active substances
ZA200600027B (en) Pharmaceutical formulations for intranasal administration of protein comprising a chitosan or a derivative thereof
EP1411876A4 (en) Configuration of implanted devices
HK1089085A1 (en) Subcutaneous delivery system, process for the preparation of the same and use of the same for the treatment of cholinergic deficient disorders